Inhibiting nonhomologous end-joining repair would promote the antitumor activity of gemcitabine in nonsmall cell lung cancer cell lines
Nannan Guo(Chinese PLA General Hospital), Wen Zhang(Xidian University), Jingbo Li(Central South University), J. Tang, Shaojun Li(Guangxi Medical University), Yun-long Zhao(Hunan University of Traditional Chinese Medicine), Ying-nan Zhao(Chinese PLA General Hospital), Bo Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Ping Chen(Macau University of Science and Technology)
Cited by 3
Related Papers
The Molecular Basis of Turcot's Syndrome
|New England Journal of Medicine|1995|1.1k
Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients
|Nature Medicine|1996|953
Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China
|New England Journal of Medicine|2013|698